rs571490973
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004562.3(PRKN):c.689C>T(p.Ala230Val) variant causes a missense change. The variant allele was found at a frequency of 0.000103 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004562.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251456Hom.: 0 AF XY: 0.000287 AC XY: 39AN XY: 135896
GnomAD4 exome AF: 0.000107 AC: 156AN: 1461624Hom.: 0 Cov.: 30 AF XY: 0.000164 AC XY: 119AN XY: 727120
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152292Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74468
ClinVar
Submissions by phenotype
Autosomal recessive juvenile Parkinson disease 2 Uncertain:1
The observed missense variant c.689C>T (p.Ala230Val) in PRKN gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Ala230Val variant has allele frequency 0.02% in gnomAD. This variant has been submitted to the ClinVar database as Uncertain Significance. The amino acid change p.Ala230Val in PRKN is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Ala at position 230 is changed to a Val changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Variant of Uncertain Significance (VUS). In the absence of another reportable variant in PRKN gene, the molecular diagnosis is not confirmed. -
not provided Uncertain:1
This sequence change replaces alanine with valine at codon 230 of the PARK2 protein (p.Ala230Val). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and valine. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. In summary, this variant is a novel missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs571490973, ExAC 0.2%) but has not been reported in the literature in individuals with a PARK2-related disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at